Product Information
AMOX-CLAV 400-57 MG/5 ML SUSP is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.0658 per ML under NDC 00143998275. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jan 25, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400; 57 mg/5mL; mg/5mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00143998275
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMOXICILLIN; CLAVULANIC ACIDApproval Type
Generic (ANDA)
FDA Application
ANDA065191FDA Approved
1/25/2005
TE Code
AB
On Market Since
12/1/2007
Pharmacological Classes
Price Statistics
The NADAC for AMOX-CLAV 400-57 MG/5 ML SUSP has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 46.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0658 per ML |
|---|---|
| All-time high | $0.1450 (Apr 16, 2014) |
| All-time low | $0.0524 (Nov 20, 2024) |
| 52-week high | $0.0737 |
| 52-week low | $0.0658 |
| Median price | $0.0921 |
| Average price | $0.0934 |
| Largest weekly change | +30.3% (Aug 19, 2020) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Amoxicillin and Clavulanate Potassium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Penicillin-class Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMOX-CLAV 400-57 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for AMOX-CLAV 400-57 MG/5 ML SUSP, manufactured by Hikma Pharmaceuticals USA Inc., is $0.0658 per ML (NDC 00143998275), effective Sep 30, 2026.
How has the price of AMOX-CLAV 400-57 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for AMOX-CLAV 400-57 MG/5 ML SUSP has declined 46.9%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for AMOX-CLAV 400-57 MG/5 ML SUSP?
Since Nov 28, 2013, the NADAC for AMOX-CLAV 400-57 MG/5 ML SUSP has ranged from a low of $0.0524 (Nov 20, 2024) to a high of $0.1450 (Apr 16, 2014), with a median of $0.0921 per ML.
Are there cheaper alternatives to AMOX-CLAV 400-57 MG/5 ML SUSP?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMOX-CLAV 400-57 MG/5 ML SUSP, is $0.0562 per ML — about 15% below AMOX-CLAV 400-57 MG/5 ML SUSP.
Who manufactures AMOX-CLAV 400-57 MG/5 ML SUSP?
AMOX-CLAV 400-57 MG/5 ML SUSP (NDC 00143998275) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.